OBJECTIVE: The purpose of this study was to determine if a prescription review service, at the time of discharge, enhances the accuracy and safety of prescriptions written at an academic pediatric hospital. METHODS: The study took place over a 30-day period and included prescriptions written for patients being discharged from the General Pediatric and Pediatric Intensive Care Services at the University of Maryland Hospital for Children, a 120-bed academic pediatric hospital. Discharge prescriptions were faxed to the Inpatient Pediatric Pharmacy where they were reviewed by a pediatric clinical pharmacist. Specific review criteria were aimed at detecting prescribing errors that included patient identification, medication selection, dosing, and therapy omission. A prescriber was notified via alpha page when errors were identified and advised on corrective measures. Interventions were compiled and analyzed to determine the overall impact of the discharge prescription review program. RESULTS: Over the 30-day period, 74 discharge prescriptions were reviewed by a pediatric clinical pharmacist. At least one prescribing error was detected in 81% of the prescriptions reviewed. Overall, 101 prescribing errors were documented and included patient identification, medication selection and dose calculation errors. The estimated cost-savings attributed to the interventions is approximately $7670. CONCLUSION: Through the discharge prescription review program, the pediatric clinical pharmacists were able to make interventions on the majority of prescriptions reviewed. The types of errors that required interventions have been identified as potential sources for major medication errors in the pediatric population. We concluded that the review of discharge prescriptions by a pediatric clinical pharmacist was an effective method of preventing prescribing errors in the pediatric environment.
OBJECTIVE: The purpose of this study was to determine if a prescription review service, at the time of discharge, enhances the accuracy and safety of prescriptions written at an academic pediatric hospital. METHODS: The study took place over a 30-day period and included prescriptions written for patients being discharged from the General Pediatric and Pediatric Intensive Care Services at the University of Maryland Hospital for Children, a 120-bed academic pediatric hospital. Discharge prescriptions were faxed to the Inpatient Pediatric Pharmacy where they were reviewed by a pediatric clinical pharmacist. Specific review criteria were aimed at detecting prescribing errors that included patient identification, medication selection, dosing, and therapy omission. A prescriber was notified via alpha page when errors were identified and advised on corrective measures. Interventions were compiled and analyzed to determine the overall impact of the discharge prescription review program. RESULTS: Over the 30-day period, 74 discharge prescriptions were reviewed by a pediatric clinical pharmacist. At least one prescribing error was detected in 81% of the prescriptions reviewed. Overall, 101 prescribing errors were documented and included patient identification, medication selection and dose calculation errors. The estimated cost-savings attributed to the interventions is approximately $7670. CONCLUSION: Through the discharge prescription review program, the pediatric clinical pharmacists were able to make interventions on the majority of prescriptions reviewed. The types of errors that required interventions have been identified as potential sources for major medication errors in the pediatric population. We concluded that the review of discharge prescriptions by a pediatric clinical pharmacist was an effective method of preventing prescribing errors in the pediatric environment.
Authors: Jerome K Wang; Nicole S Herzog; Rainu Kaushal; Christine Park; Carol Mochizuki; Scott R Weingarten Journal: Pediatrics Date: 2007-01 Impact factor: 7.124
Authors: Maisoon Abdullah Ghaleb; Nick Barber; Bryony D Franklin; Vincent W S Yeung; Zahra F Khaki; Ian C K Wong Journal: Ann Pharmacother Date: 2006-09-19 Impact factor: 3.154
Authors: Prathibha Varkey; Julie Cunningham; John O'Meara; Robert Bonacci; Nima Desai; Robert Sheeler Journal: Am J Health Syst Pharm Date: 2007-04-15 Impact factor: 2.637
Authors: Peter R Swiatek; Shepard P Johnson; Lu Wang; Mochuan Liu; Ting-Ting Chung; Kevin C Chung Journal: Ann Plast Surg Date: 2018-12 Impact factor: 1.539
Authors: Thao T Nguyen; Erica Bergeron; Teresa V Lewis; Jamie L Miller; Tracy M Hagemann; Stephen Neely; Peter N Johnson Journal: SAGE Open Med Date: 2020-06-03